HUP0400125A2 - Gyógyászati készítmény kalciumsóval bevont száraz növényi kivonatból, eljárás az elõállítására, és alkalmazása - Google Patents

Gyógyászati készítmény kalciumsóval bevont száraz növényi kivonatból, eljárás az elõállítására, és alkalmazása

Info

Publication number
HUP0400125A2
HUP0400125A2 HU0400125A HUP0400125A HUP0400125A2 HU P0400125 A2 HUP0400125 A2 HU P0400125A2 HU 0400125 A HU0400125 A HU 0400125A HU P0400125 A HUP0400125 A HU P0400125A HU P0400125 A2 HUP0400125 A2 HU P0400125A2
Authority
HU
Hungary
Prior art keywords
seed
dry extract
plant
calcium
mainly
Prior art date
Application number
HU0400125A
Other languages
English (en)
Inventor
Michael A. Popp
Original Assignee
Bionorica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7687662&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0400125(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bionorica Ag filed Critical Bionorica Ag
Publication of HUP0400125A2 publication Critical patent/HUP0400125A2/hu
Publication of HUP0400125A3 publication Critical patent/HUP0400125A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/85—Verbenaceae (Verbena family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány köpenytablettaként kialakított gyógyászati készítményrevanatkozik, amely legalább egy növényi száraz kivonatból sajtoltmagból és legalább egy, a magot körülvevő kalciumtartalmú köpenybőláll. A magot Vitex agnus castus, Belamcanda chinensis (leopardliliom),Cimicifuga racemosa (fürtös ezüstgyertya), Trifolium pratense L.(vörös lóhere), Oenothere biennis hom. (éjszakai gyertya), Glycinesoja (szójabab), Serenoa repens (fűrészpálma), Urtica dioica (csalán),főleg gyökeréből, Cucurbita pepo (tök), főleg magvából; Pygeumafricanum növényből nyert száraz kivonatból vagy azok alkalmaskeverékéből sajtolják. Ezeknek a csontritkulás ellen hatásos növényikivonatoknak a hatását fokozza, hogy a tabletta köpenye alakjábanegyidejűleg kalcium kerül a szervezetbe. Ó
HU0400125A 2001-06-08 2002-04-10 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating HUP0400125A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10127897A DE10127897B4 (de) 2001-06-08 2001-06-08 Manteltablette mit Pflanzentrockenextrakten
PCT/EP2002/004002 WO2002100422A1 (de) 2001-06-08 2002-04-10 Pharmazeutische formulierung bestehend aus einem pflanzentrockenextrakt mit einer calciumummantelung

Publications (2)

Publication Number Publication Date
HUP0400125A2 true HUP0400125A2 (hu) 2004-08-30
HUP0400125A3 HUP0400125A3 (en) 2005-11-28

Family

ID=7687662

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0400125A HUP0400125A3 (en) 2001-06-08 2002-04-10 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating

Country Status (28)

Country Link
US (2) US7629005B2 (hu)
EP (1) EP1392337B2 (hu)
JP (1) JP4945058B2 (hu)
KR (1) KR100894848B1 (hu)
CN (1) CN100376267C (hu)
AT (1) ATE311195T1 (hu)
AU (1) AU2002317720B2 (hu)
BG (1) BG66394B1 (hu)
BR (1) BR0210262A (hu)
CA (1) CA2449521C (hu)
CZ (1) CZ305121B6 (hu)
DE (2) DE10127897B4 (hu)
DK (1) DK1392337T4 (hu)
EA (1) EA006760B1 (hu)
EE (1) EE05360B1 (hu)
ES (1) ES2250674T5 (hu)
GE (1) GEP20053591B (hu)
HU (1) HUP0400125A3 (hu)
LT (1) LT5146B (hu)
LV (1) LV13127B (hu)
MX (1) MXPA03011102A (hu)
NO (1) NO20035274D0 (hu)
NZ (1) NZ529779A (hu)
PL (1) PL370446A1 (hu)
RO (1) RO122659B1 (hu)
SK (1) SK287722B6 (hu)
UA (1) UA76464C2 (hu)
WO (1) WO2002100422A1 (hu)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10127897B4 (de) † 2001-06-08 2006-04-20 Bionorica Ag Manteltablette mit Pflanzentrockenextrakten
US6767560B2 (en) * 2002-01-22 2004-07-27 Paul H Paek Fabrication method of oral care composition
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
US20050238739A1 (en) * 2004-04-23 2005-10-27 Thomas Nisslein Composition comprising a combination of calcium, cimicifugae racemosae rhizoma and vitamin D and its use as a pharmaceutical in conditions or disorders associated with or resulting from calcium deficiency or as a nutritional supplement
US20060039971A1 (en) * 2004-08-19 2006-02-23 Lee Robert E Effervescent composition including alternative hormone replacement therapy agent
EP1745796A1 (de) * 2005-07-19 2007-01-24 Bionorica Research GmbH Kombinationspräparat insbesondere zur Therapie des Prostatakarzinoms
FR2893848B1 (fr) * 2005-11-28 2011-11-11 Physcience Composition phytohormonale et son utilisation comme substitut hormonal
RU2428193C2 (ru) * 2006-02-17 2011-09-10 Виридис Фармасьютикал Лимитед Средство, ускоряющее абсорбцию кальция
KR100758265B1 (ko) * 2006-04-07 2007-09-13 한국생명공학연구원 트리테르페노이드계 화합물을 유효성분으로 함유하는 심혈관계 질환의 예방 및 치료용 조성물
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
US8221803B1 (en) 2007-06-25 2012-07-17 OncoNatural Solutions, Inc. Composition for prostate health
DE102008012988A1 (de) 2008-03-07 2009-09-10 S.W. Patentverwertungs Ltd. Zusammensetzung und Verwendungen zur Beeinflussung des Haarwachstums
WO2013007807A1 (de) 2011-07-12 2013-01-17 Bionorica Se Ausgewählte cimicifuga-fraktionen zur behandlung von osteoporose
EP2545932A1 (de) 2011-07-12 2013-01-16 Bionorica Se Ausgewählte Cimicifuga-Fraktionen zur Behandlung von Osteoporose
WO2013074046A1 (en) 2011-08-08 2013-05-23 Mahmut Bilgic Pharmaceutical formulations comprising isoflavone
EP2559438A1 (de) 2011-08-19 2013-02-20 Bionorica Se Verfahren zur Herstellung von Trockenextrakten
ES2545152T3 (es) 2011-08-19 2015-09-08 Bionorica Se Procedimiento para la preparación de extractos secos
WO2013033087A2 (en) 2011-09-02 2013-03-07 Burt's Farm, LLC Personal care compositions comprising squash or pumpkin extract
EP2606902A1 (de) 2011-12-19 2013-06-26 Bionorica SE Extrakt aus Rhus copallina als Arzneimittel
EP2620155A1 (de) 2012-01-30 2013-07-31 Bionorica SE Arzneimittel enthaltend Cimicifuga zur Anwendung bei der Behandlung von Sarkopenie und Herzmuskelschwäche
EP2810650A1 (de) * 2013-06-06 2014-12-10 Bionorica Se Arzneimittel enthaltend Thymian und Primel oder Thymian und Efeu als PDE-4-Hemmer
JP2014237608A (ja) * 2013-06-07 2014-12-18 株式会社日本食品薬化 エストロゲン様作用剤、メラニン産生抑制作用剤、皮膚外用剤および美容用飲食品
WO2015020191A1 (ja) * 2013-08-09 2015-02-12 日東薬品工業株式会社 カルシウム剤
HUE040375T2 (hu) 2014-10-17 2019-03-28 Bionorica Se Canephron vizelési kényszer és prosztatagyulladás kezelésére
CN104800324A (zh) * 2015-05-11 2015-07-29 李汶峰 一种治疗前列腺肥大的中药
WO2022133555A1 (pt) * 2020-12-23 2022-06-30 Lithocálcio Indústria, Comércio, Importação, Exportação E Representação Ltda. Composição farmacêutica sólida contendo vitamina d e sal de cálcio, método para tratar ou prevenir condições relacionadas a baixa ingestão e/ou maior necessidade de cálcio, uso da composição farmacêutica sólida e produto farmacêutico ou suplementar

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2410417A (en) * 1944-03-04 1946-11-05 Lever Brothers Ltd Vitamin and mineral dietary supplement and method of making
NL255509A (hu) * 1959-09-02
US3345265A (en) * 1963-10-09 1967-10-03 Kendall & Co Multiple layer tablet with calcium salt central core separated from soluble fluoride outer coating
JPS59155309A (ja) * 1983-02-22 1984-09-04 Teijin Ltd 活性型ビタミンｄ↓３類組成物
US4681766A (en) * 1986-01-07 1987-07-21 Warner-Lambert Company Coatings for chewing gums containing gum arabic and a soluble calcium salt
US4752479A (en) * 1986-05-27 1988-06-21 Ciba-Geigy Corporaton Multi vitamin and mineral dietary supplement with controlled release bioavailable iron
US4915948A (en) * 1987-08-31 1990-04-10 Warner-Lambert Company Tablets having improved bioadhesion to mucous membranes
US4996061A (en) * 1987-10-07 1991-02-26 Merrell Dow Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol-decongestant combination
US5093130A (en) * 1989-09-26 1992-03-03 Plant Genetics Powder coated hydrogel capsules
EP0610060A1 (en) 1993-02-01 1994-08-10 Conrad Gorinsky Bisbenzylisoquinoline derivatives
DE4431653C2 (de) * 1994-09-06 2000-01-20 Lohmann Therapie Syst Lts Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung
US5569459A (en) * 1995-02-15 1996-10-29 Bio-Virus Research Incorporated Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders
JPH0930977A (ja) * 1995-07-20 1997-02-04 Tsuneo Nanba 升麻抽出物を含有する骨疾患治療剤
US5948443A (en) * 1996-02-23 1999-09-07 Medical Doctor's Research Institute, Inc. Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
US6139872A (en) * 1996-08-14 2000-10-31 Henkel Corporation Method of producing a vitamin product
DE19652183C1 (de) * 1996-12-14 1998-02-12 Schaper & Bruemmer Gmbh Verwendung eines Extraktes aus Cimicifuga racemosa
GB9709082D0 (en) * 1997-05-06 1997-06-25 Ciba Geigy Ag Organic compositions
ATE246039T1 (de) * 1997-09-09 2003-08-15 Select Release L C Beschichtete teilchen, methode zu ihrer herstellung und verwendung
CN1179972A (zh) 1997-09-29 1998-04-29 杨成玉 多能口洁泡腾片
US6004558A (en) * 1998-02-25 1999-12-21 Novogen, Inc. Methods for treating cancer with legume plant extracts
DE19812204A1 (de) 1998-03-19 1999-11-04 Plantamed Arzneimittel Gmbh Verwendung von Extrakten aus Cimicifuga racemosa und Belamcanda sinensis als estrogenartiges organselektives Arzneimittel ohne uterotrope Wirkung
US20050037100A1 (en) 1998-03-19 2005-02-17 Bionorica Ag Utilization of extracts from iris plants, cimicifuga racemose and tectorigenin as an estrogen-like organ-selective medicament without uterotropic
DE19814905A1 (de) * 1998-04-02 1999-10-07 Michael O Ruepp Aar Pharma Verwendung von Bärentraubenblätter (Arctostaphylos uva ursi)-, Birkenblätter (Betula)-, Schachtelhalmkraut (Equisetum)- und Brennessel (Urtica)-Extrakten
US6444018B1 (en) * 1998-06-25 2002-09-03 Xerox Corporation Phase change ink carrier compositions containing anhydride/amino alcohol-based adducts
GB9813906D0 (en) 1998-06-26 1998-08-26 Isis Innovations Ltd Coatings
KR100267576B1 (ko) 1998-07-25 2000-11-01 허계성 활성성분을 분리함유한 츄잉 연질정제 및 그의 제조방법
WO2000006127A1 (en) 1998-07-30 2000-02-10 Warner-Lambert Company Centerfill delivery system for nutraceuticals
DE19844836A1 (de) * 1998-09-30 2000-04-20 Hexal Ag Pharmazeutisch, wirksames, pflanzliches Präparat zur Behandlung von Migräne
GB9821670D0 (en) * 1998-10-05 1998-12-02 Muhlbauer Roman C Plant extracts for the treatment of increased bone resorption
GB9825033D0 (en) * 1998-11-13 1999-01-13 Nycomed Pharma As Process
AR020343A1 (es) * 1998-11-24 2002-05-08 Steigerwald Arzlneimittelwerk Metodo para producir farmacos que contienen extractos de plantas en una forma solida de aplicacion.
US6200594B1 (en) * 1999-12-29 2001-03-13 Vital Dynamics, Inc. Breast-enhancing, herbal compositions and methods of using same
DE10127897B4 (de) 2001-06-08 2006-04-20 Bionorica Ag Manteltablette mit Pflanzentrockenextrakten

Also Published As

Publication number Publication date
LV13127B (en) 2004-05-20
UA76464C2 (uk) 2006-08-15
DK1392337T4 (da) 2009-09-21
NO20035274D0 (no) 2003-11-27
LT2004002A (en) 2004-03-25
SK16402003A3 (sk) 2004-05-04
BG108419A (en) 2004-11-30
CA2449521C (en) 2010-09-21
WO2002100422A1 (de) 2002-12-19
MXPA03011102A (es) 2004-12-06
EE200400006A (et) 2004-02-16
CN1514732A (zh) 2004-07-21
JP4945058B2 (ja) 2012-06-06
KR100894848B1 (ko) 2009-04-24
ES2250674T3 (es) 2006-04-16
HUP0400125A3 (en) 2005-11-28
PL370446A1 (en) 2005-05-30
EE05360B1 (et) 2010-12-15
BG66394B1 (bg) 2013-12-31
CZ20033578A3 (en) 2004-04-14
DE10127897A1 (de) 2002-12-19
EA200400001A1 (ru) 2004-06-24
KR20040011517A (ko) 2004-02-05
US20100068273A1 (en) 2010-03-18
ES2250674T5 (es) 2009-11-06
GEP20053591B (en) 2005-07-25
DK1392337T3 (da) 2005-12-27
US20040151781A1 (en) 2004-08-05
DE10127897B4 (de) 2006-04-20
AU2002317720B2 (en) 2007-06-21
JP2004534058A (ja) 2004-11-11
SK287722B6 (en) 2011-07-06
US7629005B2 (en) 2009-12-08
NZ529779A (en) 2006-04-28
CZ305121B6 (cs) 2015-05-13
CN100376267C (zh) 2008-03-26
EA006760B1 (ru) 2006-04-28
DE50205118D1 (de) 2006-01-05
CA2449521A1 (en) 2002-12-19
BR0210262A (pt) 2004-06-22
EP1392337A1 (de) 2004-03-03
RO122659B1 (ro) 2009-11-30
ATE311195T1 (de) 2005-12-15
EP1392337B1 (de) 2005-11-30
EP1392337B2 (de) 2009-07-22
LT5146B (lt) 2004-07-26

Similar Documents

Publication Publication Date Title
HUP0400125A2 (hu) Gyógyászati készítmény kalciumsóval bevont száraz növényi kivonatból, eljárás az elõállítására, és alkalmazása
Hartanti et al. The potential roles of jamu for COVID-19: a learn from the traditional Chinese medicine
Yarnell Herbs for viral respiratory infections
RS49963B (sr) Kompozicija koja obuhvata hranjivi materijal i biljni ekstrat korisna za prevenciju i tretiranje virusa humane imunodeficijencije i drugih infektivnih bolesti
Mali et al. Phcog Rev.: Plant review Rakta Kanchan (Bauhinia variegata): Chemistry traditional and medicinal uses—A review
Armijos et al. Antioxidant properties of medicinal plants used in the Southern Ecuador
Niazi et al. The role of plants in traditional and modern medicine
WO2002102308A3 (en) Pharmaceutical composition for the treatment of viral infection
Mir Pharmacological and phytochemical properties of Iris kashmiriana baker as a potential medicinal plant of Kashmir Himalaya
Ugwah-Oguejiofor et al. Potential medicinal plant remedies and their possible mechanisms against COVID-19: a review
Tiwari et al. Traditional medicinal plants as promising source of immunomodulator against COVID-19.
CN107050279A (zh) 百花益喘灵
HUP0104975A2 (hu) Eljárás szilárd kiszerelési formájú gyógyszerek előállítására növényi kivonatból
Doğru et al. Coronavirus Disease (COVID-19): A Review of Antiviral Potential Herbal Medicines
CN107050269A (zh) 杏仁苏子医喘丸
Wannang et al. A survey of plants used by traditional medicine practitioners in the treatment of HIV/AIDS in Plateau State, Nigeria
CN106994168A (zh) 龙牡黄芪调带药
Onyechi et al. Formulation and evaluation of allium sativum tablets for improved oral delivery
CN106975009A (zh) 山药杏仁咳喘药
Spiridonov Russian medicinal plants in treatment of cancer.
Martinus et al. Tinjauan Fitokimia dan Antioksidan Ekstrak Akar, Batang dan Daun Tumbuhan Elephantopus mollis dengan metode KLT-bioautografi
CN107050273A (zh) 麻杏喘息宁
TH40468A3 (th) ยาสมุนไพรรักษาโรคร้ายแรง และกรรมวิธีการผลิต
CN1490022A (zh) 一种治疗扁平疣的药物及其制备方法
CN106822756A (zh) 五灵荔枝丸

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished